Detection of proteolytic bond cleavage was achieved by taking advantage of
the bioluminescence emission generated by the photoprotein aequorin. A gene
tically engineered HIV-1 protease substrate was coupled with a cysteine-fre
e mutant of aequorin by employing the polymerase chain reaction to produce
a fusion protein that incorporates an optimum natural protease cleavage sit
e. The fusion protein was immobilized on a solid phase and employed as the
substrate for the HIV-1 protease. Proteolytic bond cleavage was detected by
a decrease in the bioluminescence generated by the aequorin fusion protein
on the solid phase. A dose-response curve for HIV-1 protease was construct
ed by relating the decrease in bioluminescence signal with varying amounts
of the protease. The system was also used to evaluate two competitive and o
ne noncompetitive inhibitor of the HIV-1 protease. Among the advantages of
this assay is that by using recombinant methods a complete bioluminescently
labeled protease recognition site can be designed and produced. The assay
yields very sensitive detection limits, which are inherent to bioluminescen
ce-based methods. An application of this system may be in the high-throughp
ut screening of biopharmaceutical drugs that are potential inhibitors of a
target protease. (C) 2000 Academic Press.